These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5163962)

  • 1. Polyinosinic acid-polycytidylic acid in ophthalmology. I. Ocular irritation studies in rabbits.
    McDonald TO; Fox LG; Timberlake GM; Belluscio PR; Borgmann AR
    Ann Ophthalmol; 1971 Apr; 3(4):371-6. PubMed ID: 5163962
    [No Abstract]   [Full Text] [Related]  

  • 2. Polyinosinic acid-polycytidylic acid in ophthalmology. 3. Intraocular response after intravenous, intraocular, and topical ocular administration in rabbits.
    McDonald TO; Borgmann AR
    Ann Ophthalmol; 1971 Oct; 3(10):1146-51. PubMed ID: 5163795
    [No Abstract]   [Full Text] [Related]  

  • 3. Polyinosinic acid-polycytidylic acid in ophthalmology. II. Systemic absorption after topical ocular, intravenous, and intraocular administration in rabbits.
    McDonald TO; Borgmann AR
    Ann Ophthalmol; 1971 Oct; 3(10):1135-9. PubMed ID: 5163794
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental ocular studies with polyinosinic acid: polycytidylic acid.
    McDonald TO
    Eye Ear Nose Throat Mon; 1973 Feb; 52(2):45-52. PubMed ID: 4346077
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of polyinosinic-polycytidylic acid complex on experimental acute toxoplasmic retinochoroiditis in rabbits.
    Chowchuvech E; Weissenbacher M; Schmunis G; Sawicki L; Galin MA; Baron S
    Invest Ophthalmol; 1972 Mar; 11(3):182-8. PubMed ID: 5012489
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on compatibility of tretinoin following systemic and topical application. 1. Toxicological studies].
    Kretzschmar R; Leuschner F; Neumann W; Peh J; Zeller H
    Arzneimittelforschung; 1974 Aug; 24(8):1193-9. PubMed ID: 4278561
    [No Abstract]   [Full Text] [Related]  

  • 7. [Data to the toxicology of sodium metabisulfite].
    Ezfielev GI
    Farmakol Toksikol; 1968; 31(2):246-9. PubMed ID: 5674686
    [No Abstract]   [Full Text] [Related]  

  • 8. Antagonism of arachidonic acid-induced ocular effects by delta1-tetrahydrocannabinol.
    Green K; Podos SM
    Invest Ophthalmol; 1974 Jun; 13(6):422-9. PubMed ID: 4831696
    [No Abstract]   [Full Text] [Related]  

  • 9. Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and cats.
    Lee KC; Silver PJ; Bode DC; Gherezghiher T
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):527-34. PubMed ID: 8309316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyinosinic:polycytidylic acid induces memory processing deficits in the day-old chick.
    Kent S; Dedda K; Hale MW; Crowe SF
    Behav Pharmacol; 2007 Feb; 18(1):19-27. PubMed ID: 17218794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marihuana and the eye.
    Green K
    Invest Ophthalmol; 1975 Apr; 14(4):261-3. PubMed ID: 1123282
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the pharmacology of tetracycline preparations during intravenous administration. Glycocycline].
    Storozhev IA; Eĭdel'shteĭn SI; Bykova MA
    Antibiotiki; 1966 Nov; 11(11):1017-23. PubMed ID: 5996396
    [No Abstract]   [Full Text] [Related]  

  • 13. An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic acid-polycytidylic acid and its mismatched analogues.
    Ts'o PO; Alderfer JL; Levy J; Marshall LW; O'Malley J; Horoszewicz JS; Carter WA
    Mol Pharmacol; 1976 Mar; 12(2):299-312. PubMed ID: 1264072
    [No Abstract]   [Full Text] [Related]  

  • 14. Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma.
    Farag HH; Wu WM; Barros MD; Somogyi G; Prokai L; Bodor N
    Drug Des Discov; 1997 Aug; 15(2):117-30. PubMed ID: 9342554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the cumulative properties of solasodine].
    Shashkina LF; Ryndina SE; Starkov MV; Grebennik LI; Kurilenko RP
    Farmakol Toksikol; 1974; 37(6):719-22. PubMed ID: 4464106
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of local or distal therapeutic treatment with polyinosinic-polycytidylic acid on survival of mice with Ehrlich carcinoma.
    DuBuy HG
    J Natl Cancer Inst; 1972 May; 48(5):1525-7. PubMed ID: 5030961
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of intraocular application of cyclophosphamide in the rabbit].
    Antillón F; Gómez Leal A; Arguinzoniz S
    Gac Med Mex; 1976 Jul; 112(1):61-8. PubMed ID: 964546
    [No Abstract]   [Full Text] [Related]  

  • 18. Biopharmaceutical factors influencing LD50. I. Viscosity.
    Ritschel WA; Siegel EG; Ring PE
    Arzneimittelforschung; 1974 Jun; 24(6):907-10. PubMed ID: 4408167
    [No Abstract]   [Full Text] [Related]  

  • 19. An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic-polycytidylic acid duplex and its mismatched analogues. III. Chronic effects and immunological features.
    Carter WA; O'Malley J
    Mol Pharmacol; 1976 May; 12(3):440-53. PubMed ID: 180397
    [No Abstract]   [Full Text] [Related]  

  • 20. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.